Target intelligence / Profile preview

RNY1 pseudogene 7 (RNY1P7)

Target
RNY1P7
Molecular classification
Pseudogene, Non-coding RNA (ncRNA), Long non-coding RNA (lncRNA) (applies since many pseudogenes are classified as lncRNAs), Other
01

Overview

RNY1 pseudogene 7 (RNY1P7) is a human pseudogene belonging to the Y RNA family, which are small non-coding RNAs primarily associated with the Ro ribonucleoprotein complex[5]. Y RNAs, including their pseudogenes, generally function in the regulation of DNA replication, gene expression, and RNA stability, sometimes acting as competing endogenous RNAs (ceRNAs) to regulate microRNA availability and modulate mRNA degradation or translation[2][6]. RNY1P7 itself does not encode a functional protein and is classified as a pseudogene by the Human Gene Nomenclature Committee (HGNC)[5]. Although many Y RNA and related pseudogenes have implications in cancer, autoimmune disease, and immune regulation, there is no evidence that RNY1P7 is a direct therapeutic target or has validated biomarker or drug interactions. Its close relatives, functional Y RNAs, are known to interact with immune receptors including Toll-like receptors (TLRs), and altered Y RNA expression has been observed in several cancers and autoimmune diseases; however, these functions have not been specifically attributed to RNY1P7 itself[1][3][7].

Other names
RNY1P7RNA, Ro-associated Y1 pseudogene 7
02

Biological functions

Competing endogenous RNA (ceRNA) activity (potential/implied via general pseudogene functions)Regulation of gene expression (post-transcriptional)Other
03

Disease associations

Other (some RNY1 family Y RNAs and pseudogenes have been associated with cancer and immune diseases, but there is no evidence specifically implicating RNY1P7)

Beyond the preview

Go deeper on RNY1 pseudogene 7 (RNY1P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNY1 pseudogene 7 (RNY1P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call